Experience

Eurofins Transplant Genomics

• United States
• Biotechnology Research
• 1 - 100 Employee

• Regional Transplant Manager

  • Oct 2022 - Present

  Transplant Genomics is committed to improving organ transplant outcomes with noninvasive serial monitoring guided by genomics.



CareDx, Inc.

• United States
• Biotechnology Research
• 400 - 500 Employee

• Sr. Transplant Account Manager

  • Jul 2019 - Mar 2022

  Pennsylvania CareDx: Transforming Transplant Patient Care Through Novel Surveillance Management Solutions CareDx, Inc. is dedicated to improving the lives of organ transplant patients through non-invasive diagnostics. By combining the latest advances in genomics and bioinformatics technology, with a commitment to generating high quality clinical evidence through trials and registries, CareDx is at the forefront of organ transplant surveillance and pre-transplant HLA typing solutions.



PANTHERx Rare Pharmacy

• United States
• Pharmaceutical Manufacturing
• 100 - 200 Employee

• National Account Manager

  • Oct 2018 - Jul 2019

  National - Establish, maintain and expand strategic partnerships with pharmaceutical manufacturers and other trade partners in traditional and rare disease specialty drug markets. - Responsible for customer retention, meeting sales/financial goals and strategic objectives. - Lead Trade/Channel solution development efforts that best address customer needs by understanding client's business goals, market challenges and infrastructure.

• Manager, Key Accounts

  • Aug 2015 - Oct 2018

  Greater Pittsburgh Area -Recruited to a start-up Specialty Pharmacy to sell pharmacy services to physician and hospital patient referral sources. Specialty and Rare Disease drugs are the primary focus. Clinical call points include Transplant, Hepatology, Dermatology, Infectious Disease and Anti-Coagulant therapeutic areas. Developed Transplant, Infectious Disease and Hospital/Acute Care Rx referral markets, including the implementation of patient referral and patient on-boarding processes to increase medication… Show more -Recruited to a start-up Specialty Pharmacy to sell pharmacy services to physician and hospital patient referral sources. Specialty and Rare Disease drugs are the primary focus. Clinical call points include Transplant, Hepatology, Dermatology, Infectious Disease and Anti-Coagulant therapeutic areas. Developed Transplant, Infectious Disease and Hospital/Acute Care Rx referral markets, including the implementation of patient referral and patient on-boarding processes to increase medication adherence and improved clinical outcomes for our patients.



Plexision

• United States
• Biotechnology
• 1 - 100 Employee

• US Sales and Marketing Manager- Solid Organ Transplant

  • Apr 2014 - Sep 2015

  National As a biotech startup, Plexision develops celluar biomarkers for personalized diagnosis and drug development in solid organ transplantation and immunological disorders. Plexision's immune monitoring assay, Pleximmune, is FDA approved for use in pediatric liver and intestine transplant patients to predict acute cellular rejection. Responsibilites included Clinical Business Development, US Transplant Center/Hospital and Payor Account Management, Reimbursement and Patient Assistance.



Giant Eagle, Inc.

• United States
• Retail Groceries
• 700 & Above Employee

• Regional Account Manager, Specialty Pharmacy Sales

  • Jun 2012 - Jan 2014

  Pennsylvania, Ohio and West Virginia Concentration in Pittsburgh, Cleveland and Columbus -Recruited to help launch start-up Specialty Pharmacy division for 225 store supermarket/pharmacy chain. Solely responsible for solid organ transplant, liver disease and Crohn’s/Ulcerative Colitis prescription sales and patient referrals. Joint responsibility for Oncology, Hematology and Rheumatology prescription sales -Expanded Hepatitis-C prescription sales from $55K to over $1.2M in 9 months … Show more Concentration in Pittsburgh, Cleveland and Columbus -Recruited to help launch start-up Specialty Pharmacy division for 225 store supermarket/pharmacy chain. Solely responsible for solid organ transplant, liver disease and Crohn’s/Ulcerative Colitis prescription sales and patient referrals. Joint responsibility for Oncology, Hematology and Rheumatology prescription sales -Expanded Hepatitis-C prescription sales from $55K to over $1.2M in 9 months -Implemented and sold Transplant patient referral program direct to hospital departments that led to a sales increase of approximately $3M -Developed complete liver disease patient referral and adherence platforms, including Hepatitis-B, Hepatitis-C drugs and vaccines, leading to double digit Rx growth within therapeutic areas Show less



Avella Specialty Pharmacy

• United States
• Pharmaceutical Manufacturing
• 100 - 200 Employee

• Regional Account Manager, Transplant and Infectious Disease

  • Jul 2011 - Jun 2012

  Pennsylvania, Ohio, Indiana and Michigan -Sold Specialty Pharmacy services directly to Transplant, Gastroenterology and Hepatology clinicians and staff, in both medical center and office-based settings. Targeted customers include physicians, nurses, social workers, administrators and patients - Responsible for monthly sales of over $2 million. Averaged 20 new patient referrals per month, including transplant, liver disease and HIV patients



Pfizer

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Transplant Account Manager

  • Nov 2002 - Mar 2011

  Promoted, November 2002 Pennsylvania, Ohio and Michigan -Responsible for sales of the anti-rejection drug, Rapamune, used by transplant clinicians including Transplant Surgeons, Transplant Pharmacists and Nephrologists -Sold Vfend, an Anti-Fungal, in a highly competitive Medical Center Anti-Infective marketplace -Supported Rapamune education and Patient Access Assistance for Transplant Coordinators, Nurses… Show more Promoted, November 2002 Pennsylvania, Ohio and Michigan -Responsible for sales of the anti-rejection drug, Rapamune, used by transplant clinicians including Transplant Surgeons, Transplant Pharmacists and Nephrologists -Sold Vfend, an Anti-Fungal, in a highly competitive Medical Center Anti-Infective marketplace -Supported Rapamune education and Patient Access Assistance for Transplant Coordinators, Nurses, Pharm D’s, Social Workers and other Transplant personnel. Developed relationships and advocacy with many key opinion leaders in the fields of immunology and transplantation - Conducted informed data and science driven clinical presentations to transplant teams and individual physicians using approved reprints and slide presentations -Facilitated adoption of FDA approved Rapamune assay by collaborating with Lab Directors, Transplant Clinicians and Abbott Labs -Trained, coached and mentored several new Transplant Account Managers in role as Field Trainer -Achieved largest de novo Rapamune market share increase in nation, 2004 -Maintained a large three state geography with responsibility for 14 Transplant Centers, including the world- renowned Thomas E. Starzl Transplant Institute at UPMC, Allegheny General and Cleveland Clinic -Additional account relationships: University Hospitals, Univ. of Toledo Medical Center, Harrisburg, Hershey Medical Center, Geisinger, Lehigh Valley and Children’s Hospital of Pittsburgh -Wyeth Achievement Award Winner, 2007 (Top 10%) -Pfizer Vice President's Cabinet Award Winner, 2010 (Top 3%)

• Musculoskeletal Specialty Manager

  • Apr 2001 - Dec 2002

  Promoted April 2001 Promoted into elite new division, responsible solely for sales of Synvisc, an injectable intra-articular device for treatment of osteoarthritis of the knee. -Responsible for geography encompassing one third of Pennsylvania, calling on approximately 75 key orthopedic and rheumatology offices. Unlike a pharmaceutical, Synvisc was purchased directly by orthopedic surgeons, rheumatologists and some third party payers -From 2001 to 2003 increased… Show more Promoted April 2001 Promoted into elite new division, responsible solely for sales of Synvisc, an injectable intra-articular device for treatment of osteoarthritis of the knee. -Responsible for geography encompassing one third of Pennsylvania, calling on approximately 75 key orthopedic and rheumatology offices. Unlike a pharmaceutical, Synvisc was purchased directly by orthopedic surgeons, rheumatologists and some third party payers -From 2001 to 2003 increased Synvisc sales from $1.7 million to $2.8 million in a highly competitive market, well above both national and zone averages. Thrived in a very entrepreneurial selling environment -Selected to train new Specialty Managers on sales training/data analysis and product information -Coordinated and resolved buy and bill reimbursement issues -Developed an innovative program for an influential Managed Care organization resulting in a large increase in Synvisc sales for the entire Western and Central Pennsylvania regions -Wyeth Impact Award Winner, 2001

• Territory Representative

  • Apr 1999 - Apr 2001

  Customer base included primary care physicians, orthopedic surgeons, rheumatologists and gastroenterologists. Responsible for managing a portfolio of 3 pharmaceutical products and 1 device, each in a separate therapeutic drug class: Enbrel, Effexor XR and Protonix. Generated sales for Synvisc, an FDA approved device, by selling directly to orthopedic surgeons and rheumatologists. -Consistently among top sales performers in District, including successful launches of Enbrel and… Show more Customer base included primary care physicians, orthopedic surgeons, rheumatologists and gastroenterologists. Responsible for managing a portfolio of 3 pharmaceutical products and 1 device, each in a separate therapeutic drug class: Enbrel, Effexor XR and Protonix. Generated sales for Synvisc, an FDA approved device, by selling directly to orthopedic surgeons and rheumatologists. -Consistently among top sales performers in District, including successful launches of Enbrel and Protonix -Increased volume of Synvisc kits sold to 693 kits in 2000 from 388 kits, 1999 (180%) -Grew Effexor XR baseline market share by 17% from 6.20% to 9.22% in the year 2000 -Wyeth Rookie of the Year Award winner